Regional cerebral metabolic alterations in dementia of the alzheimer type: Positron emission tomography with [18f]fluorodeoxyglucose

Journal of Computer Assisted Tomography

Volumn 7, Issue 4, 1983, Pages 590-598

  Friedland, Robert P ^a,b   Budinger, Thomas F ^a,c   Ganz, Edward ^a,c   Yano, Yukio ^a,c   Mathis, Chester A ^a,c   Koss, Betty ^a,b,c   Ober, Beth A ^a,b   Huesman, Ronald H ^a,c   Derenzo, Steven E ^a,c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Age and Aging; Alzheimer disease; Computed tomography; Dementia; Emission computed tomography; 18F Fluorodeoxyglucose

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOISOTOPE;

AGED; ALZHEIMER DISEASE; BRAIN METABOLISM; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; COMPUTER ANALYSIS; DEMENTIA; DIAGNOSIS; DRUG ACCUMULATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; METHODOLOGY; POSITRON EMISSION TOMOGRAPHY;

AGED; ALZHEIMER DISEASE; CEREBRAL CORTEX; DEMENTIA; DEOXY SUGARS; DEOXYGLUCOSE; FEMALE; FLUORINE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; RADIOISOTOPES; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0020594056     PISSN: 03638715     EISSN: 15323145     Source Type: Journal    
DOI: 10.1097/00004728-198308000-00003     Document Type: Article

References (76)

1. Jacoby RJ, Levy R, Dawson JM., Computed tomography in the elderly: 1. The normal population. Br J Psychiatry 1980;136:249-55.
2. Hughes CP, Gado M., Computed tomography and aging of the brain. Radiology 1981;139:391-6.
3. Zatz LM, Jemigan TL, Ahumada AJ Jr. Changes on computed cranial tomography with aging: intracranial fluid volume. Am J Neuroradiol 1982;3:1-11.
4. Hagberg B, Ingvar DH., Cognitive reduction in presenile dementia related to regional abnormalities of the cerebral blood flow. Br J Psychiatry 1976;128:209-22.
5. Gustafson L, Brun A, Ingvar DH., Presenile dementia: clinical symptoms, pathoanatomical findings, and cerebral blood flow. In: Meyer JS, Lechner H, Reivich M, eds. Cerebrovascular diseases, proceedings of the 8th International Salzburg Conference. Amsterdam: Excerpta Medica, 1977:5-9.
6. Johannesson G, Brun A, Gustafson I, Ingvar DH., EEG in presenile dementia related to cerebral blood flow and autopsy findings. Acta Neurol Scand 1977;56:89-103.
7. Gustafson L, Hagberg B, Ingvar DH., Speech disturbances in presenile dementia related to local cerebral blood flow abnormalities in the dominant hemisphere. Brain Lang 1978;5:103-18.
8. Stigsby B, Johannesson G, Ingvar DH., Regional EEG analysis and regional cerebral blood flow in Alzheimer’s and Pick’s disease. Electroencephalogr Clin Neurophysiol 1981;51:537-47.
9. Melamed E, Lavy S, Siew F, Bentin S, Cooper G., Correlation between regional cerebral blood flow and brain atrophy in dementia: combined study with 133xenon inhalation and computerized tomography. J Neurol Neurosurg Pyschiatry 1978;41:494-9.
10. Tomlinson BE, Henderson G., Some quantitative cerebral findings in normal and demented old people. In: Terry RD, Gershon S, eds. Aging, Vol 3. Neurobiology of aging. New York: Raven Press, 1976:183-209.
11. Terry RD., Senile dementia. Fed Proc 1978;37:2837-40.
12. Terry RD, Peck A, DeTeresa R, Schechter R, Horoupian DS., Some morphometric aspects of the brain in senile dementia of the Alzeheimer type. Ann Neurol 1981;10:184-92.
13. Phelps ME, Huang S-C, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE., Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18) 2-fluoro-2- deoxy-d-glucose: validation of method. Ann Neurol 1979;6:371-88.
14. Sokoloff L, Reivich M, Kennedy C, DesRosiers MH, Patlak CS, Pettigrew KD, Sakurada O, Shinohara M., The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J Neurochem 1977;28:897-916.
15. Kennedy C, Sakurada O, Shinohara M, Jehle J, Sokoloff L., Local cerebral glucose utilization in the normal conscious macaque monkey. Ann Neurol 1978;4:293-301.
16. Sokoloff L., Relation between physiological function and energy metabolism in the central nervous system. J Neurochem 1977;29:13-26.
17. Sokoloff L., Mapping of local cerebral functional activity by measurement of local cerebral glucose utilization with [14C]deoxyglucose. Brain 1979;102:653-68.
18. Kuhl DE, Engel J Jr., Phelps ME, Selin C., Epileptic patterns of local cerebral metabolism and perfusion in humans determined by emission computed tomography of 18FDG and 13NH3. Ann Neurol 1980;8:348-60.
19. Kuhl DE, Phelps ME, Kowell AP, Metter EJ, Selin C, Winter J., Effects of stroke on local cerebral metabolism and perfusion: mapping by emission computed tomography of 18FDG and 13NH3. Ann Neurol 1980;8:47-60.
20. Mazziotta JC, Phelps ME, Miller J, Kuhl DE., Tomographic mapping of human cerebral metabolism: normal unstimulated state. Neurology (NY) 1981;31:503-16.
21. Phelps ME, Mazziotta JC, Huang S-C., Study of cerebral function with positron computed tomography. J Cereb Blood Flow Metab 1982;2:113-62.
22. Metter EJ, Riege WH, Phelps MF., Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F]-fluorodeoxyglucose method. J Cereb Blood Flow Metab 1982;2:163-71.
23. Mazziotta JC, Phelps ME, Carson RE, Kuhl DE., Tomographic mapping of human cerebral metabolism: sensory deprivation. Ann Neurol 1982;12:435-44.
24. Hachinski VC, Iliff LD, Phil M, Zilhka E, du Boulay GH, McAllister VL, Marshall J, Russell RWR, Symon L., Cerebral blood flow in dementia. Arch Neurol 1975;32:632-7.
25. Harrison MJG, Thomas DJ, du Boulay GH, Marshall J., Multi-infarct dementia. J Neurol Sci 1979;40:97-103.
26. Rosen WG, Terry RD, Fuld PA, Katzman R, Peck A., Pathological verification of ischaemia score in differentiation of dementias. Ann Neurol 1980;7:486-8.
27. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Washington, DC, 1980:124-6.
28. Mattis S., Mental status examination for organic mental syndrome in the elderly patient. In: Beliak L, Katasu T, eds. Geriatric psychiatry: a handbook for psychiatrists and primary care physicians, Vol. 7. New York: Grune and Stratton, 1976:77-121.
29. Corkin S., Some relationships between global amnesias and the memory impairments in Alzheimer’s disease. In: Corkin S, Davis KL, Growdon JH, Usdin E, Wurtman RJ, eds. Aging, Vol 19. Alzheimer's disease: a report of progress in research. New York: Raven Press, 1982:149-64.
30. Rosen WG, Mohs RC., Evolution of cognitive decline in dementia. Corkin S, Davis KL, Growdon JH, Usdin E, Wurtman RJ, eds. Aging, Vol 19. Alzheimer’s disease: a report of progress in research. New York: Raven Press, 1982;183-9.
31. Huesman RH, Cahoon JL., Data acquisition, reconstruction and display for the Donner 280-crystal positron tomograph. IEEE Trans Nucl Sci 1980;NS-27:474-8.
32. Derenzo SE, Budinger TF, Huesman RH, Cahoon JL, Vuletich T., Imaging properties of a positron tomograph with 280 BGO crystals. IEEE Trans Nucl Sci 1981;NS-28:81-9.
33. Derenzo SE, Budinger TF, Vuletich T., High resolution PET using small BGO crystals and individual photosensors. IEEE Trans Nucl Sci 1983;NS-30:665-70.
34. Ido T, Wan C-N, Casella V, Fowler JS, Wolf AP, Reivich M, Kuhl D., Labeled 2-deoxy-d-glucose analogs. 18F-Labeled 2-deoxy-2-fluoro-d-glucose, 2-deoxy-2-fluoro-d-mannose and 14C-2-deoxy-2-fluoro-d-glucose. J Label Comp Radiopharm 1978;14:175-83.
35. Matsui T, Hirano A., An atlas of the human brain for computerized tomography. Tokyo: Igaku-Shoin, 1978:151.
36. Reivich M, Kuhl D, Wolf A, Greenberg J, Phelps M, Ido T, Casella V, Fowler J, Hoffman E, Alavi A, Som P, Sokoloff L., The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 1979;44:127-37.
37. Budinger TF, Derenzo SE, Greenberg WL, Gullberg GT, Huesman RH., Quantitative potentials of dynamic emission computed tomography. J Nucl Med 1978;19:309-15.
38. Riege WH, Kuhl DE, Phelps ME., Relations among mea- sures of local cerebral glucose metabolism in healthy adults. Abstr Soc Neurosci 1982;8:917.
39. Tomlinson BE, Blessed G, Roth M., Observations on the brains of demented old people. J Neurol Sei 1970; 11: 205-42.
40. Hubbard BM, Anderson JM., A quantitative study of cerebral atrophy in old age and senile dementia. J Neurol Sei 1981;50:135-45.
41. Brun A, Gustafson L., Distribution of cerebral degeneration in Alzheimer’s disease: a clinico-pathological study. Arch Psychiatrie Nervenkrankneiten 1976;223:15-33.
42. Hooper MW, Vogel FS., The limbic system in Alzheimer's disease: a neuropathologic investigation. Am J Pathol 1976;85:1-20.
43. Gustafson L., Regional cerebral blood flow in Alzheimer’s disease-differential diagnosis, the possibility of early recognition and evaluation of treatment. In: Glen AIM, Whalley LJ, eds. Alzheimer’s disease: early recognition of potentially reversible deficits. London: Churchill Livingstone, 1979: 102-7.
44. Davies P., Neurotransmitter related enzymes in senile dementia of the Alzheimer type. Brain Res 1979;171:319-27.
45. Perry EK, Perry RH., The cholinergic system in Alzheimer's disease. In: Roberts PJ., Biochemistry of dementia. New York: John Wiley and Sons, 1980:135-84.
46. Rossor MN, Garrett NJ, Johnson AL, Mountjoy CQ, Roth M, Iversen LL., A post-mortem study of the cholinergic and gaba systems in senile dementia. Brain 1982;105:313-30.
47. Gado MH, Hughes CP, Danziger W, Chi D, Jost G, Berg L., Volumetric measurements of the cerebrospinal fluid spaces in demented subjects and controls. Radiology 1982; 144: 535-8.
48. De Leon MJ, Ferris SH, George AE, Reisberg B, Kricheff II, Gershon S., Computed tomography evaluations of brain- behavior relationships in senile dementia of the Alzheimer’s type. Neurobiol Aging 1980;1:69-79.
49. Ford CV, Winter J., Computerized axial tomograms and dementia in elderly patients. J Gerontol 1980;36:164-9.
50. Jacoby RJ, Levy R., Computed tomography in the elderly. 2. Senile dementia: diagnosis and functional impairment. Br J Psychiatry 1980;136:256-69.
51. Wu S, Schenkenberg T, Wing D, Osborn AG., Cognitive correlates of diffuse cerebral atrophy determined by computed tomography. Neurology (NY) 1981;31:1180-4.
52. Soininen H, Partanen JV, Puranen M, Riekkinen PJ., EEG and computed tomography in the investigation of patients with senile dementia. J Neurol Neurosurg Psychiatry 1982;45:711-4.
53. Soininen H, Puranen M, Riekkinen PJ., Computed tomography findings in senile dementia and normal aging. J Neurol Neurosurg Psychiatry 1982;45:50-4.
54. Brinkman SD, Sarwar M, Levin HS, Morris HH III., Quantitative indexes of computed tomography in dementia and normal aging. Radiology 1981;138:89-92.
55. Ingvar DH, Gustafson L., Regional cerebral blood flow in organic dementia with early onset. Acta Neurol Scand 1970;46:42-73, suppl 43.
56. Ingvar DH, Risberg J, Schwartz MS., Evidence of subnormal function of association cortex in presenile dementia. Neurology (NY) 1975;25:964-74.
57. Lavy S, Melamed E, Bentin S, Cooper G, Rinot Y., Bihemi-spheric decreases of regional cerebral blood flow in dementia: correlation with age-matched normal controls. Ann Neurol 1978;4:445-50.
58. Yamaguchi F, Meyer JS, Yamamoto M, Sakai F, Shaw T., Non-invasive regional cerebral blood flow measurements in dementia. Arch Neurol 1980;37:410-8.
59. Frackowiak RSJ, Pozzilli C, Legg NJ, DU Boulay GH, Marshall J, Lenzi GL, Jones T., Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography. Brain 1981;104:753-78.
60. Lassen NA, Feinberg I, Lane MH., Bilateral studies of cerebral oxygen uptake in young and aged normal subjects and in patients with organic dementia. J Clin Invest 1960; 39:491-500.
61. Klee A., The relationship between clinical evaluation of mental deterioration, psychological test results, and the cerebral metabolic rate of oxygen. Acta Neurol Scand 1964;40:337-45.
62. Dekoninck WJ, Jacquy J, Jocquet PH, Noel G., Cerebral blood flow and metabolism in senile dementia. In: Meyer JS, Lechner H, Reivich M, eds. Cerebrovascular disease. Amsterdam: Excerpta Medica, 1977:29-32.
63. Grubb RL Jr, Raichle ME, Gado MH, Eichling JO, Hughes CP., Cerebral blood flow, oxygen utilization, and blood volume in dementia. Neurology (NY) 1977;27:905-10.
64. Hoyer S., Cerebral blood flow, electroencepholography and behavior. In: Platt D, ed. Geriatrics. I., Cardiology and vascular system, central nervous system. Berlin: Springer- Verlag, 1982:201-26.
65. Gottstein U, Bemsmeier A, Sedlmeyer I., Der Kohlenhy- dratstoffwechsel des menschlichen Gehirns. II., Untersuchungen mit substratspezifischen enzymatischen Methoden bei Kranken mit verminderter Hirndurchblutung auf dem Boden einer Arteriosklerose der Hirngefaße. Klin Wochenschr 1964;42:310-3.
66. Alavi A, Ferris S, Wolf A, Reivich M, Farkas T, Dann R, Christman D, MacGregor RR, Fowler J., Determination of cerebral metabolism in senile dementia using F-18- deoxyglucose and positron emission tomography [Abstract]. J Nucl Med 1980;21:21.
67. Ferris SH, De Leon MJ, Wolf AP, Farkas T, Christman DR, Reisberg B, Fowler JS, MacGregor R, Goldman A, George AE, Rampal S., Positron emission tomography in the study of aging and senile dementia. Neurobiol Aging 1980; 1: 127-31.
68. Benson DF, Kuhl DE, Phelps ME, Cummings JL, Tsai SY., Positron emission computed tomography in the diagnosis of dementia [Abstract]. Ann Neurol 1981; 10:76.
69. Farkas T, Ferris SH, Wolf AP, De Leon MJ, Christman DR, Reisberg B, Alavi A, Fowler JS, George AE, Reivich M., 18F-2-Deoxy-2-fluoro-D-glucose as a tracer in the positron emission tomographic study of senile dementia. Am J Psychiatry 1982;139:352-3.
70. Benson DF., The use of positron emission scanning techniques in the diagnosis of Alzheimer’s disease. In: Corkin S, Davis KL, Growdon JH, UsdinE, Wurtman RL, eds. Aging, Vol 19. Alzheimer’s disease: a report of progress in research. New York: Raven Press, 1982;79-82.
71. Friedland RP, Budinger TF, Yano Y, et al. Regional cerebral metabolic alterations in Alzheimer-type dementia: kinetic studies with 18-fluorodeoxyglucose [Abstr]. J Cerebr Blood Flow Metab (in press).
72. Mazziotta JC, Phelps ME, Plummer D, Kuhl DE., Quantitation in positron emission computed tomography: 5. Physical-anatomical effects. J Comput Assist Tomogr 1981; 5:734-43.
73. Kelly PAT, Mc Culloch JM., A potential error in modifications of the [14C]2-deoxyglucose technique. Brain Res 1983; 260:172-7.
74. Ingvar D., Functional activation in the diseased brain. In: Zulch KJ, Kaufmann W, Hossmann K-A, Hossmann V, eds. Brain and heart infarct II., Berlin: Springer-Verlag, 1979:232-9.
75. Ladurner G, Ott EO, Perry PJ, Stix P, Schreyer H, Wiedner F, Lechner H., Bilateral measurement of regional cerebral blood flow in dementia. In: Meyer JS, Lechner H, Reivich M, eds. Cerebrovascular diseases, proceedings of the 8th International Salzburg Conference. Amsterdam: Excerpta Medica 1977:10-3.
76. Dahl D, Selkoe DJ, Pevo RT, Bignami A., Immunostaining of neurofibrillary tangles in Alzheimer’s senile dementia with a neurofilament antiserum. J Neurosci 1982;2:113-9.